Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
financials
Pharma
Lilly shines in Q4 as peers brace for 2026 slowdown
As drugmakers reported their fourth-quarter and 2025 sales, its guidance for 2026 was noteworthy as most companies are projecting a growth decline.
Kevin Dunleavy
Mar 11, 2026 3:00pm
CSL details sales slide behind recent leadership transition
Feb 12, 2026 8:29am
Samsung Bio ekes ahead of Korea biopharma peers with great 2025
Jan 22, 2026 8:15am
Lilly blows out tirzepatide sales expectations, raises guidance
Oct 30, 2025 10:39am
AstraZeneca plots NYSE listing amid UK industry pullback
Sep 29, 2025 10:05am
Sarepta extends $700M debt to 2030 amid Elevidys uncertainty
Aug 21, 2025 10:52am
